Correction of a pathogenic gene mutation in human embryos

Hong Ma, Nuria Marti-Gutierrez, Sang Wook Park, Jun Wu, Yeonmi Lee, Keiichiro Suzuki, Amy Koski, Dongmei Ji, Tomonari Hayama, Riffat Ahmed, Hayley Darby, Crystal Van Dyken, Ying Li, Eunju Kang, A. Reum Park, Daesik Kim, Sang Tae Kim, Jianhui Gong, Ying Gu, Xun Xu & 11 others David Battaglia, Sacha A. Krieg, David Lee, Diana Wu, Don P. Wolf, Stephen Heitner, Juan Carlos Izpisua Belmonte, Paula Amato, Jin Soo Kim, Sanjiv Kaul, Shoukhrat Mitalipov

Research output: Contribution to journalArticle

306 Citations (Scopus)

Abstract

Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.

Original languageEnglish (US)
Pages (from-to)413-419
Number of pages7
JournalNature
Volume548
Issue number7668
DOIs
StatePublished - Aug 24 2017

Fingerprint

Embryonic Structures
Mutation
Genes
Clustered Regularly Interspaced Short Palindromic Repeats
Preimplantation Diagnosis
Mosaicism
Germ-Line Mutation
Blastocyst
DNA Repair
Cell Cycle
Alleles
Mothers
Safety
DNA

ASJC Scopus subject areas

  • General

Cite this

Ma, H., Marti-Gutierrez, N., Park, S. W., Wu, J., Lee, Y., Suzuki, K., ... Mitalipov, S. (2017). Correction of a pathogenic gene mutation in human embryos. Nature, 548(7668), 413-419. https://doi.org/10.1038/nature23305

Correction of a pathogenic gene mutation in human embryos. / Ma, Hong; Marti-Gutierrez, Nuria; Park, Sang Wook; Wu, Jun; Lee, Yeonmi; Suzuki, Keiichiro; Koski, Amy; Ji, Dongmei; Hayama, Tomonari; Ahmed, Riffat; Darby, Hayley; Van Dyken, Crystal; Li, Ying; Kang, Eunju; Park, A. Reum; Kim, Daesik; Kim, Sang Tae; Gong, Jianhui; Gu, Ying; Xu, Xun; Battaglia, David; Krieg, Sacha A.; Lee, David; Wu, Diana; Wolf, Don P.; Heitner, Stephen; Belmonte, Juan Carlos Izpisua; Amato, Paula; Kim, Jin Soo; Kaul, Sanjiv; Mitalipov, Shoukhrat.

In: Nature, Vol. 548, No. 7668, 24.08.2017, p. 413-419.

Research output: Contribution to journalArticle

Ma, H, Marti-Gutierrez, N, Park, SW, Wu, J, Lee, Y, Suzuki, K, Koski, A, Ji, D, Hayama, T, Ahmed, R, Darby, H, Van Dyken, C, Li, Y, Kang, E, Park, AR, Kim, D, Kim, ST, Gong, J, Gu, Y, Xu, X, Battaglia, D, Krieg, SA, Lee, D, Wu, D, Wolf, DP, Heitner, S, Belmonte, JCI, Amato, P, Kim, JS, Kaul, S & Mitalipov, S 2017, 'Correction of a pathogenic gene mutation in human embryos', Nature, vol. 548, no. 7668, pp. 413-419. https://doi.org/10.1038/nature23305
Ma H, Marti-Gutierrez N, Park SW, Wu J, Lee Y, Suzuki K et al. Correction of a pathogenic gene mutation in human embryos. Nature. 2017 Aug 24;548(7668):413-419. https://doi.org/10.1038/nature23305
Ma, Hong ; Marti-Gutierrez, Nuria ; Park, Sang Wook ; Wu, Jun ; Lee, Yeonmi ; Suzuki, Keiichiro ; Koski, Amy ; Ji, Dongmei ; Hayama, Tomonari ; Ahmed, Riffat ; Darby, Hayley ; Van Dyken, Crystal ; Li, Ying ; Kang, Eunju ; Park, A. Reum ; Kim, Daesik ; Kim, Sang Tae ; Gong, Jianhui ; Gu, Ying ; Xu, Xun ; Battaglia, David ; Krieg, Sacha A. ; Lee, David ; Wu, Diana ; Wolf, Don P. ; Heitner, Stephen ; Belmonte, Juan Carlos Izpisua ; Amato, Paula ; Kim, Jin Soo ; Kaul, Sanjiv ; Mitalipov, Shoukhrat. / Correction of a pathogenic gene mutation in human embryos. In: Nature. 2017 ; Vol. 548, No. 7668. pp. 413-419.
@article{4f286da3e64e4762976f4924ff4f379f,
title = "Correction of a pathogenic gene mutation in human embryos",
abstract = "Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.",
author = "Hong Ma and Nuria Marti-Gutierrez and Park, {Sang Wook} and Jun Wu and Yeonmi Lee and Keiichiro Suzuki and Amy Koski and Dongmei Ji and Tomonari Hayama and Riffat Ahmed and Hayley Darby and {Van Dyken}, Crystal and Ying Li and Eunju Kang and Park, {A. Reum} and Daesik Kim and Kim, {Sang Tae} and Jianhui Gong and Ying Gu and Xun Xu and David Battaglia and Krieg, {Sacha A.} and David Lee and Diana Wu and Wolf, {Don P.} and Stephen Heitner and Belmonte, {Juan Carlos Izpisua} and Paula Amato and Kim, {Jin Soo} and Sanjiv Kaul and Shoukhrat Mitalipov",
year = "2017",
month = "8",
day = "24",
doi = "10.1038/nature23305",
language = "English (US)",
volume = "548",
pages = "413--419",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7668",

}

TY - JOUR

T1 - Correction of a pathogenic gene mutation in human embryos

AU - Ma, Hong

AU - Marti-Gutierrez, Nuria

AU - Park, Sang Wook

AU - Wu, Jun

AU - Lee, Yeonmi

AU - Suzuki, Keiichiro

AU - Koski, Amy

AU - Ji, Dongmei

AU - Hayama, Tomonari

AU - Ahmed, Riffat

AU - Darby, Hayley

AU - Van Dyken, Crystal

AU - Li, Ying

AU - Kang, Eunju

AU - Park, A. Reum

AU - Kim, Daesik

AU - Kim, Sang Tae

AU - Gong, Jianhui

AU - Gu, Ying

AU - Xu, Xun

AU - Battaglia, David

AU - Krieg, Sacha A.

AU - Lee, David

AU - Wu, Diana

AU - Wolf, Don P.

AU - Heitner, Stephen

AU - Belmonte, Juan Carlos Izpisua

AU - Amato, Paula

AU - Kim, Jin Soo

AU - Kaul, Sanjiv

AU - Mitalipov, Shoukhrat

PY - 2017/8/24

Y1 - 2017/8/24

N2 - Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.

AB - Genome editing has potential for the targeted correction of germline mutations. Here we describe the correction of the heterozygous MYBPC3 mutation in human preimplantation embryos with precise CRISPR-Cas9-based targeting accuracy and high homology-directed repair efficiency by activating an endogenous, germline-specific DNA repair response. Induced double-strand breaks (DSBs) at the mutant paternal allele were predominantly repaired using the homologous wild-type maternal gene instead of a synthetic DNA template. By modulating the cell cycle stage at which the DSB was induced, we were able to avoid mosaicism in cleaving embryos and achieve a high yield of homozygous embryos carrying the wild-type MYBPC3 gene without evidence of off-target mutations. The efficiency, accuracy and safety of the approach presented suggest that it has potential to be used for the correction of heritable mutations in human embryos by complementing preimplantation genetic diagnosis. However, much remains to be considered before clinical applications, including the reproducibility of the technique with other heterozygous mutations.

UR - http://www.scopus.com/inward/record.url?scp=85026999487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026999487&partnerID=8YFLogxK

U2 - 10.1038/nature23305

DO - 10.1038/nature23305

M3 - Article

VL - 548

SP - 413

EP - 419

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7668

ER -